<DOC>
	<DOCNO>NCT00003800</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure may improve doctor 's ability predict recurrence testicular cancer . PURPOSE : Diagnostic trial detect risk recurrent disease patient stage I testicular cancer undergone orchiectomy within previous 12 week .</brief_summary>
	<brief_title>Diagnostic Study Patients With Stage I Testicular Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Use histopathological immunohistological analysis primary testis tumor along quantitative radiographic assessment identify subset patient clinical stage I nonseminomatous germ cell tumor testis low risk metastasis . - Compare finding predictive model risk metastasis orchiectomy group patient . OUTLINE : Patients undergo primary retroperitoneal lymph node dissection ( RPLND ) active surveillance management disease . The choice treatment determine physician patient . Patients pathologically positive resect lymph node may undergo treatment ( observation adjuvant chemotherapy ) investigator 's discretion . All patient test quantitative radiology blood marker ( HCG AFP ) baseline various time surgery identify pathologic stage II disease . The timing study depend stage disease and/or type disease management . Patients undergo RPLND , stage I II disease , receive adjuvant therapy ( radiation chemotherapy ) follow monthly year 1 , every 2 month year 2 , every 6 month year 3-5 , annually thereafter . Patients undergo RPLND , stage II disease , receive adjuvant therapy follow every 2 month year 1 , every 4 month year 2 , every 6 month year 3-5 , annually thereafter . Patients undergo RPLND follow monthly year 1 , every month year 2 , every 6 month year 3-5 , annually thereafter . PROJECTED ACCRUAL : A total 315 patient accrue study within 3 year .</detailed_description>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Clinical stage I nonseminomatous germ cell tumor testis Must radical inguinal orchiectomy without retroperitoneal lymph node dissection within prior 12 week AFP HCG normal decrease orchiectomy rate consistent know half live Pathology block radiologic study available No metastatic disease physical exam chest abdominal/pelvic CT No pure seminoma ( unless associate elevated AFP diagnosis ) PATIENT CHARACTERISTICS : Age : 15 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No prior malignancy include prior primary testicular cancer PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : See Disease Characteristics</criteria>
	<gender>Male</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>stage I malignant testicular germ cell tumor</keyword>
	<keyword>stage II malignant testicular germ cell tumor</keyword>
	<keyword>testicular embryonal carcinoma</keyword>
	<keyword>testicular choriocarcinoma</keyword>
	<keyword>testicular teratoma</keyword>
	<keyword>testicular yolk sac tumor</keyword>
	<keyword>testicular embryonal carcinoma teratoma</keyword>
	<keyword>testicular embryonal carcinoma yolk sac tumor</keyword>
	<keyword>testicular yolk sac tumor teratoma</keyword>
	<keyword>testicular choriocarcinoma yolk sac tumor</keyword>
	<keyword>testicular choriocarcinoma embryonal carcinoma</keyword>
	<keyword>testicular choriocarcinoma teratoma</keyword>
</DOC>